Suppr超能文献

混合感染中产β-内酰胺酶的细菌。

Beta-lactamase-producing bacteria in mixed infections.

作者信息

Brook I

机构信息

Department of Pediatrics, Georgetown University School of Medicine, Washington DC 20016, USA.

出版信息

Clin Microbiol Infect. 2004 Sep;10(9):777-84. doi: 10.1111/j.1198-743X.2004.00962.x.

Abstract

Beta-lactamase-producing bacteria (BLPB) can play an important role in polymicrobial infections. They can have a direct pathogenic impact in causing infections, as well as an indirect effect through their ability to produce the beta-lactamase. BLPB may not only survive penicillin therapy themselves, but can also protect other penicillin-susceptible bacteria from penicillin by releasing free beta-lactamase into their immediate environment. This phenomenon occurs in upper respiratory tract, skin, soft tissue, surgical and other infections. The in-vitro and in-vivo clinical evidence supporting the role of BLPB in the increasing failure of penicillin to resolve such infections, and the implications of this phenomenon for the management of infections, are discussed.

摘要

产β-内酰胺酶细菌(BLPB)在混合感染中可发挥重要作用。它们在引起感染方面可产生直接的致病影响,同时通过产生β-内酰胺酶的能力产生间接作用。BLPB不仅自身能在青霉素治疗下存活,还可通过向周围环境释放游离的β-内酰胺酶来保护其他对青霉素敏感的细菌免受青霉素影响。这种现象发生在上呼吸道、皮肤、软组织、外科手术及其他感染中。本文讨论了支持BLPB在青霉素治疗此类感染失败率增加中作用的体外和体内临床证据,以及这一现象对感染管理的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验